title: Lessons from bcl-2 transgenic mice for immunology, cancer biology and cell death research.
abstract: The protein product of the proto-oncogene bcl-2, originally discovered by virtue of its chromosomal translocation in human follicular centre B cell lymphoma, is a physiological inhibitor of programmed cell death, apoptosis. Initial studies in transgenic mice overexpressing Bcl-2 in B or T lymphocytes demonstrated that Bcl-2 can potently antagonise cell death induced by multiple independent signal transduction routes and can contribute to oncogenesis, particularly in combination with other oncogenes, like c-myc, that promote cell proliferation. Further investigations using crosses between bcl-2 transgenic mice and T cell receptor or immunoglobulin transgenic mice or mutant mice deficient in proper antigen receptor gene rearrangement demonstrated that Bcl-2 can only block death of cells that failed to receive a positive stimulus, "death by neglect', but not activation induced apoptosis. Collectively, these results provide evidence that distinct signalling pathways for apoptosis converge upon a common effector machinery where Bcl-2 acts as an antagonist, but that there also exists a mechanism that can either bypass the Bcl-2 checkpoint or override its protective function. These experimental data are reviewed here and discussed in context of current knowledge of lymphocyte differentiation, tumorigenesis and cell death regulation.
authors.affiliation: Walter and Eliza Hall Institute of Medical Research, PO Royal Melbourne Hospital, Victoria, Australia.
authors.forename: A
authors.initials: A
authors.lastname: Strasser
authors.forename: L
authors.initials: L
authors.lastname: O'Connor
authors.forename: D C
authors.initials: DC
authors.lastname: Huang
authors.forename: L A
authors.initials: LA
authors.lastname: O'Reilly
authors.forename: M L
authors.initials: ML
authors.lastname: Stanley
authors.forename: M L
authors.initials: ML
authors.lastname: Bath
authors.forename: J M
authors.initials: JM
authors.lastname: Adams
authors.forename: S
authors.initials: S
authors.lastname: Cory
authors.forename: A W
authors.initials: AW
authors.lastname: Harris
mesh_terms: D000818:Animals; D017209:Apoptosis; D001402:B-Lymphocytes / Q000276:immunology; D016923:Cell Death; D002455:Cell Division; D019254:Genes, bcl-2; D006801:Humans; D051379:Mice; D008822:Mice, Transgenic; D008954:Models, Biological; D009369:Neoplasms / Q000235:genetics / Q000503:physiopathology*; D000090063:Proto-Oncogene Mas; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000096:biosynthesis / Q000276:immunology / Q000502:physiology*; D013601:T-Lymphocytes / Q000276:immunology
chemical_list: C000715470:MAS1 protein, human; D000090063:Proto-Oncogene Mas; D019253:Proto-Oncogene Proteins c-bcl-2